序号 |
标题 |
次数 |
作者 |
发布时间 |
541 |
DSPC-Hyd-Dextran 二硬脂酰基磷脂酰胆碱-腙键-葡聚糖 DSPC-Hyd-PEG-Dextran |
455 |
axc |
2023-04-23 |
542 |
Fmoc-NH-PEG9-COOH 1191064-81-9 小分子PEG |
489 |
LYQ |
2023-04-23 |
543 |
DSPC-Hyd-NOTA 二硬脂酰基磷脂酰胆碱-腙键-大环配体 DSPC-Hyd-PEG-NOTA |
468 |
axc |
2023-04-23 |
544 |
DSPC-PEG-DOX 二硬脂酰基磷脂酰胆碱-聚乙二醇-阿霉素 DSPC-PEG2000-DOX |
511 |
axc |
2023-04-20 |
545 |
DSPC-PEG-PCL 二硬脂酰基磷脂酰胆碱-聚乙二醇-聚已内酯 DSPC-ss-PCL |
456 |
axc |
2023-04-20 |
546 |
Fmoc-NH-PEG36-COOH 850312-72-0 Fmoc-NH-PEG36-CH2CH2COOH PEG(聚乙二醇)试剂 |
623 |
LYQ |
2023-04-20 |
547 |
DSPC-PEG-Alkyne 二硬脂酰基磷脂酰胆碱-聚乙二醇-炔基 DSPC-Alkyne |
557 |
axc |
2023-04-19 |
548 |
DSPC-PEG-NHS 二硬脂酰基磷脂酰胆碱-聚乙二醇-N-聚乙二醇-羟基琥珀酰亚胺 DSPC-NHS |
521 |
axc |
2023-04-19 |
549 |
DSPE-DBCO DBCO功能化二硬脂酰磷脂酰乙醇胺 西安齐岳生物 |
452 |
axc |
2023-04-19 |
550 |
DSPE-CHO 醛基功能化二硬脂酰磷脂酰乙醇胺 参数信息 |
438 |
axc |
2023-04-19 |
551 |
18:1 Biotinyl Cap PE cas:384835-51-2 生物素功能化二油酰基磷脂酰乙醇胺 |
647 |
axc |
2023-04-19 |
552 |
16:0 Ptd Thioethanol cas:474923-39-2 巯基改性二棕榈酰磷脂酰乙醇 |
511 |
axc |
2023-04-19 |
553 |
18:1 MPB PE cas:384835-49-8 马来酰亚胺改性二油酰基磷脂酰乙醇胺 |
527 |
axc |
2023-04-19 |
554 |
DSPE-Hyd-PEG-MAL 马来酰亚胺聚乙二醇-腙键-二硬脂酰基磷脂酰乙醇胺 |
462 |
axc |
2023-04-19 |
555 |
Biotin-PEG3-SPA 1253286-56-4 Biotin-PEG3-NHS PEG衍生物 |
431 |
LYQ |
2023-04-18 |
556 |
Biotin-PEG4-SPA 459426-22-3 Biotin-PEG4-NHS PEG衍生物 |
481 |
LYQ |
2023-04-18 |
557 |
LA-PEG2-OH 1674386-82-3 Lipoamido-PEG2-OH 小分子PEG |
465 |
LYQ |
2023-04-17 |
558 |
CAS:4235-95-4 二油酰基磷脂酰胆碱 DOPC (18:1 PC) 产品描述 |
600 |
axc |
2023-04-14 |
559 |
Alkyne-PEG3-NHS 1428629-71-3 PEG修饰剂 |
486 |
LYQ |
2023-04-14 |
560 |
cas:474945-22-7 12:0 EPC chloride(阳离子磷脂) |
721 |
axc |
2023-04-13 |
561 |
Thalidomide-O-PEG4-Propargyl 2098799-77-8 萨力多胺-O-四聚乙二醇-炔 |
462 |
LYQ |
2023-04-13 |
562 |
17:0-22:4 PC-d5|1-heptadecanoyl-2-docosatetraenoyl-sn-glycero(d5)-3-phosphocholine |
518 |
axc |
2023-04-10 |
563 |
17:0 Lyso PC-d5|1-heptadecanoyl-2-hydroxy-sn-glycero(d5)-3-phosphocholine |
484 |
axc |
2023-04-10 |
564 |
17:0-14:1 PC-d5|1-heptadecanoyl-2-myristoleoyl-sn-glycero(d5)-3-phosphocholine |
468 |
axc |
2023-04-10 |
565 |
14:0 PC-d9|1,2-dimyristoyl-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9磷脂 |
434 |
axc |
2023-04-10 |
566 |
14:0 PC-d63|1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 |
444 |
axc |
2023-04-10 |
567 |
16:0 PC-d4|1,2-dipalmitoyl-sn-glycero-3-phosphocholine-1,1,2,2-d4磷脂 |
489 |
axc |
2023-04-10 |
568 |
16:0 PC-d62|1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine磷脂 |
476 |
axc |
2023-04-10 |
569 |
16:0-d31-18:1 PC|1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine 磷脂 |
485 |
axc |
2023-04-10 |
570 |
N3-PEG6-CH2COOH 880129-82-8 Azide-PEG6-CH2COOH PEG试剂 |
444 |
LYQ |
2023-04-10 |
571 |
16:0-Pyr PC|1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphatidylcholine|PC磷脂 |
991 |
axc |
2023-04-10 |
572 |
18:1(11-cis) PC|1,2-divaccenoyl -sn-glycero-3-phosphocholine|PC磷脂 |
449 |
axc |
2023-04-10 |
573 |
16:1 (Δ9-Trans) PC|1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
549 |
axc |
2023-04-10 |
574 |
18:1 (Δ9-Trans) PC|1,2-dielaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
971 |
axc |
2023-04-10 |
575 |
06:0 Lyso PC|1-hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine 磷脂PC |
539 |
axc |
2023-04-07 |
576 |
2-18:1 Lyso PC|1-hydroxy-2-oleoyl-sn-glycero-3-phosphocholine PC类磷脂 |
446 |
axc |
2023-04-07 |
577 |
20:0 Lyso PC|1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine PC类磷脂 |
431 |
axc |
2023-04-07 |
578 |
N3-PEG4-SPA 944251-24-5 PEG修饰剂 |
496 |
LYQ |
2023-04-07 |
579 |
聚偏二氟乙烯/聚丙烯腈海水淡化膜 ,聚偏二氟乙烯/共六氟丙烯海水淡化膜 |
531 |
zyl |
2023-04-06 |
580 |
mPEG6-N3 1043884-49-6 PEG修饰剂 |
459 |
LYQ |
2023-04-06 |
581 |
酶抑制剂靶点预测|药物靶点评估|化合物库定制 |
679 |
zyl |
2023-04-04 |
582 |
细胞膜修饰脂质体/蛋白/聚合物纳米载体/磁性纳米粒子 |
484 |
zyl |
2023-04-04 |
583 |
cas:90429-66-6 Tempol-d17,15N 活性氧簇 |
524 |
axc |
2023-04-04 |
584 |
Topo I/COX-2-IN-2 活性氧抑制剂运输条件 |
478 |
axc |
2023-04-04 |
585 |
CAS:2133360-04-8 Pomalidomide-NH-CO-PEG1-N3 PEG衍生物 |
552 |
LYQ |
2023-04-04 |